The risk of intracranial hemorrhage in glioma patients receiving anticoagulant treatment for venous thromboembolism: a bayesian network meta-analysis.

Huasong HuoShurui ShenYin YangHongwei ZhangShouwang WuTaiyu BiYunqian Li

Published in: Journal of thrombosis and thrombolysis (2023)

It seems that LMWH has the highest risk of ICH in glioma patients, while no evidence indicates that DOACs increase the risk of ICH. The use of DOACs may perhaps be a better choice. Further larger studies focusing on the benefit-to-risk ratio are warranted.

Keyphrases

venous thromboembolism
direct oral anticoagulants
systematic review
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
atrial fibrillation
case control
patient reported outcomes
decision making
smoking cessation